Clinical Trial Update: Trastuzumab in Combination With Capecitabine and Oxaliplatin(XELOX) in Patients With Advanced Gastric Cancer(AGC): Her+XELOX [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating trastuzumab with XELOX in HER2-positive advanced gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastric Cancer

Drugs mentioned

• Trastuzumab (trastuzumab)
• XELOX (capecitabine + oxaliplatin)

Snippet

Sponsor: Asan Medical Center | Conditions: Metastatic or Recurrent Gastric Adenocarcinoma, Her-2 Positive Gastric Cancer | Phase 2 | Status: COMPLETED